Freshly Printed - allow 10 days lead
Couldn't load pickup availability
The Future of Drug Discovery
Who Decides Which Diseases to Treat?
A thought-provoking book that analyzes the current challenges of the pharmaceutical industry in meeting societal needs and discusses risk mitigation and potential innovative solutions for developing these new and necessary therapeutics in the future
Tamas Bartfai (Author), Graham V. Lees (Author)
9780124071803
Paperback, published 3 July 2013
376 pages, 5 illustrations
22.9 x 15.1 x 2.4 cm, 0.6 kg
"This book reviews in exquisite detail the drug development process from the initial inception of an idea through the life cycle of a new drug entity. The authors also spend an appropriate amount of time on the role of government-funded research programs along with the role of medium and small biotechnology companies in the drug treatment of diseases…Summing Up: Highly recommended." --CHOICE Reviews Online, December 2013 "Bartfai and Lees describe the looming crisis in health care…They target society in general as their audience, because of the need for the public to understand what is happening and why they should be concerned. The book is a compendium of data and analysis and there are many tables and figures supporting the text." --Reference and Research Book News, August 2013 "A remarkable compendium of hard data and wise prescription for the pharmaceutical industry." --Michael S. Brown, 1985 Novel Laureate in Medicine or Physiology, UT Southwestern Medical Center "This is an extraordinary, insightful and provocative book that should be read by all those concerned by the progress of biomedicine, from scientists to politicians." --Jean-Pierre Changeux, Collège de France and l’Institut Pasteur "Bartfai and Lees raise critical issues confronting the search for new medicines. Their analysis is cogent, and their proposals thoughtful and thought provoking. For anyone curious about where new medicines come from, and what it will take for the BioPharma industry to bring new treatments to patients with Alzheimer's disease, diabetes, depression, cancer, and more, this is a must read." --Michael D. Ehlers, Senior VP Pfizer and CSO Neuroscience, former Howard Hughes Investigator, Duke University "This book is a must read for students, prescribing physicians, academic and industry researchers, analysts, patient groups, business and science journalists, and importantly, Policy Makers. More than ever before, drug development is a complex scientific, industrial and societal endeavour that needs the combined attention of Governments, Academics and Big Pharma; it cannot be left to Wall Street alone." --Daniel Hoyer, Chair, Department of Pharmacology, University of Melbourne, former Novartis Leading Scientist
Approx.342 pages
00 – Introduction for the non-specialist 01 – Why there will be new drugs despite the ongoing ‘crisis’ of drug development in big pharma 02 – The need for medicine grows 03 – Medicines are becoming better 04 – Which diseases do we want to treat? 05 – Therapeutic Areas: strategically important diseases for the future 06 – Blockbuster proprietary drugs versus generic drugs 07 – Why is pharma a special industry? 08 – Diagnosing towards personalized medicine 09 – Personalized medicine 10 – How much can drugs cost? 11 – Modeling Drug Discovery until 2025 12 – Drug development models between 2010 and 2025
Subject Areas: Pharmacology [MMG], Pharmaceutical industries [KNDP]
